Speaker: Evan Berk, PhD, Global R&D Lead, Metabolic Health, Nestle Health Science
This program was recorded on October 30, 2019
- Gain an understanding of what are medium chain triglycerides
- Historical uses of MCTs as a therapeutic agent in disease management
- Emerging and novel application of MCT for disease management
RDs and DTRs practicing in the US may log CPE activities under Activity Type 175 for up to three years from the original presentation date. This program is eligible for 1 CPEU. The activity number for viewing the recording through October 30, 2022 is 152215 (level 1,2,3).
Vitaflo will not provide a CE certificate for this activity. We encourage individuals to follow CDR guidance: Documentation to Retain: Print-out of hosting website. Please print this page for your records. To learn more about submitting this activity type visit CDR.
The Therapeutic Role of Medium Chain Triglycerides Edited from Vitaflo USA.